Terumo : Issued its First U.S. Dollar-Denominated Senior Unsecured Notes

Press Release Terumo Issued its First U.S. Dollar-Denominated Senior Unsecured Notes TOKYO, JAPAN - April 30, 2026 - Terumo Corporation (TSE: 4543) today announced that, as part of its initiatives to diversify its funding sources and to expand access to global capital markets, it has issued its first U.S. dollar-denominated senior unsecured notes, with settlement completed on April 28, 2026.

Summary of Terumo Corporation's First U.S. Dollar-Denominated Senior Unsecured Notes

1. Principal amount	US$ 500 million
2. Tenor	5 years
3. Interest rate	4.488% per annum
4. Issue price	100% of principal amount
5. Issue and settlement date	April 28, 2026
6. Interest payment dates	April 28 and October 28 of each year
7. Maturity date	April 28, 2031 (bullet repayment at maturity)
8. Use of proceeds	Allocation to general corporate purposes and the refinancing of a portion of the funds borrowed for the acquisition of OrganOx with long-term financing
9. Joint lead managers	Morgan Stanley & Co. International plc Goldman Sachs International Merrill Lynch International Citigroup Global Markets Limited
10. Credit rating	A- (S&P Global Ratings Japan Inc.)
11. Listing exchange	Singapore Exchange Securities Trading Limited

Note: This press release has been prepared solely for the purpose of publicly announcing the issuance of the Notes by Terumo Corporation and does not constitute, nor is it intended to constitute an offer to sell or a solicitation of an offer to buy or acquire any securities, or an invitation for any such offer, whether in Japan, the United States, or any other jurisdiction.

This press release does not constitute an offer of the Notes in any jurisdiction, including the United States. The Notes may not be offered or sold in the United States or to U.S. persons (as defined in Regulation S under the U.S. Securities Act of 1933), unless the Notes are registered under the U.S. Securities Act of 1933 or an exemption from the registration requirements thereof is available. If an offering or sale of securities is made in the United States, it will be conducted by means of a prospectus prepared in accordance with the U.S. Securities Act of 1933. No offering or sale of the Notes is made in the United States in connection with this transaction.

About Terumo

Terumo (TSE: 4543) is a global medical innovation company. Guided by an unwavering commitment to patients, and driven by the passion of our associates, we strive to fulfill our Group Mission of "Contributing to Society through Healthcare." Founded in Tokyo in 1921, we provide a comprehensive range of solutions in the fields of therapeutic procedures, hospital operations, and life sciences in more than 160 countries and regions.